List of Tables
Table 1. Global Biologic Medications for Psoriasis Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Biologic Medications for Psoriasis Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Biologic Medications for Psoriasis Market Competitive Situation by Manufacturers in 2023
Table 4. Global Biologic Medications for Psoriasis Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Biologic Medications for Psoriasis Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Biologic Medications for Psoriasis Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Biologic Medications for Psoriasis Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Biologic Medications for Psoriasis Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Biologic Medications for Psoriasis, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Biologic Medications for Psoriasis, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Biologic Medications for Psoriasis, Product Type & Application
Table 12. Global Key Manufacturers of Biologic Medications for Psoriasis, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Biologic Medications for Psoriasis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologic Medications for Psoriasis as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Biologic Medications for Psoriasis Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Biologic Medications for Psoriasis Sales by Region (2019-2024) & (K Units)
Table 18. Global Biologic Medications for Psoriasis Sales Market Share by Region (2019-2024)
Table 19. Global Biologic Medications for Psoriasis Sales by Region (2025-2030) & (K Units)
Table 20. Global Biologic Medications for Psoriasis Sales Market Share by Region (2025-2030)
Table 21. Global Biologic Medications for Psoriasis Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Biologic Medications for Psoriasis Revenue Market Share by Region (2019-2024)
Table 23. Global Biologic Medications for Psoriasis Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Biologic Medications for Psoriasis Revenue Market Share by Region (2025-2030)
Table 25. North America Biologic Medications for Psoriasis Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Biologic Medications for Psoriasis Sales by Country (2019-2024) & (K Units)
Table 27. North America Biologic Medications for Psoriasis Sales by Country (2025-2030) & (K Units)
Table 28. North America Biologic Medications for Psoriasis Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Biologic Medications for Psoriasis Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Biologic Medications for Psoriasis Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Biologic Medications for Psoriasis Sales by Country (2019-2024) & (K Units)
Table 32. Europe Biologic Medications for Psoriasis Sales by Country (2025-2030) & (K Units)
Table 33. Europe Biologic Medications for Psoriasis Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Biologic Medications for Psoriasis Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Biologic Medications for Psoriasis Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Biologic Medications for Psoriasis Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Biologic Medications for Psoriasis Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Biologic Medications for Psoriasis Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Biologic Medications for Psoriasis Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Biologic Medications for Psoriasis Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Biologic Medications for Psoriasis Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Biologic Medications for Psoriasis Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Biologic Medications for Psoriasis Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Biologic Medications for Psoriasis Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Biologic Medications for Psoriasis Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Biologic Medications for Psoriasis Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Biologic Medications for Psoriasis Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Biologic Medications for Psoriasis Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Biologic Medications for Psoriasis Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Biologic Medications for Psoriasis Sales (K Units) by Type (2019-2024)
Table 51. Global Biologic Medications for Psoriasis Sales (K Units) by Type (2025-2030)
Table 52. Global Biologic Medications for Psoriasis Sales Market Share by Type (2019-2024)
Table 53. Global Biologic Medications for Psoriasis Sales Market Share by Type (2025-2030)
Table 54. Global Biologic Medications for Psoriasis Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Biologic Medications for Psoriasis Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Biologic Medications for Psoriasis Revenue Market Share by Type (2019-2024)
Table 57. Global Biologic Medications for Psoriasis Revenue Market Share by Type (2025-2030)
Table 58. Global Biologic Medications for Psoriasis Price (US$/Unit) by Type (2019-2024)
Table 59. Global Biologic Medications for Psoriasis Price (US$/Unit) by Type (2025-2030)
Table 60. Global Biologic Medications for Psoriasis Sales (K Units) by Application (2019-2024)
Table 61. Global Biologic Medications for Psoriasis Sales (K Units) by Application (2025-2030)
Table 62. Global Biologic Medications for Psoriasis Sales Market Share by Application (2019-2024)
Table 63. Global Biologic Medications for Psoriasis Sales Market Share by Application (2025-2030)
Table 64. Global Biologic Medications for Psoriasis Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Biologic Medications for Psoriasis Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Biologic Medications for Psoriasis Revenue Market Share by Application (2019-2024)
Table 67. Global Biologic Medications for Psoriasis Revenue Market Share by Application (2025-2030)
Table 68. Global Biologic Medications for Psoriasis Price (US$/Unit) by Application (2019-2024)
Table 69. Global Biologic Medications for Psoriasis Price (US$/Unit) by Application (2025-2030)
Table 70. Bristol-Myers Squibb Company Information
Table 71. Bristol-Myers Squibb Description and Business Overview
Table 72. Bristol-Myers Squibb Biologic Medications for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Bristol-Myers Squibb Biologic Medications for Psoriasis Product
Table 74. Bristol-Myers Squibb Recent Developments/Updates
Table 75. Amgen Company Information
Table 76. Amgen Description and Business Overview
Table 77. Amgen Biologic Medications for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Amgen Biologic Medications for Psoriasis Product
Table 79. Amgen Recent Developments/Updates
Table 80. Tiefenbacher Pharmaceuticals Company Information
Table 81. Tiefenbacher Pharmaceuticals Description and Business Overview
Table 82. Tiefenbacher Pharmaceuticals Biologic Medications for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Tiefenbacher Pharmaceuticals Biologic Medications for Psoriasis Product
Table 84. Tiefenbacher Pharmaceuticals Recent Developments/Updates
Table 85. UCB Company Information
Table 86. UCB Description and Business Overview
Table 87. UCB Biologic Medications for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. UCB Biologic Medications for Psoriasis Product
Table 89. UCB Recent Developments/Updates
Table 90. Janssen Biotech Company Information
Table 91. Janssen Biotech Description and Business Overview
Table 92. Janssen Biotech Biologic Medications for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Janssen Biotech Biologic Medications for Psoriasis Product
Table 94. Janssen Biotech Recent Developments/Updates
Table 95. Eli Lilly Company Information
Table 96. Eli Lilly Description and Business Overview
Table 97. Eli Lilly Biologic Medications for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Eli Lilly Biologic Medications for Psoriasis Product
Table 99. Eli Lilly Recent Developments/Updates
Table 100. AbbVie Biotechnology Company Information
Table 101. AbbVie Biotechnology Description and Business Overview
Table 102. AbbVie Biotechnology Biologic Medications for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. AbbVie Biotechnology Biologic Medications for Psoriasis Product
Table 104. AbbVie Biotechnology Recent Developments/Updates
Table 105. Dalian Yawei Pharmaceutical Company Information
Table 106. Dalian Yawei Pharmaceutical Description and Business Overview
Table 107. Dalian Yawei Pharmaceutical Biologic Medications for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Dalian Yawei Pharmaceutical Biologic Medications for Psoriasis Product
Table 109. Dalian Yawei Pharmaceutical Recent Developments/Updates
Table 110. Novartis Company Information
Table 111. Novartis Description and Business Overview
Table 112. Novartis Biologic Medications for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Novartis Biologic Medications for Psoriasis Product
Table 114. Novartis Recent Developments/Updates
Table 115. Ortho Dermatologics Company Information
Table 116. Ortho Dermatologics Description and Business Overview
Table 117. Ortho Dermatologics Biologic Medications for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Ortho Dermatologics Biologic Medications for Psoriasis Product
Table 119. Ortho Dermatologics Recent Developments/Updates
Table 120. LEO Pharma Company Information
Table 121. LEO Pharma Description and Business Overview
Table 122. LEO Pharma Biologic Medications for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. LEO Pharma Biologic Medications for Psoriasis Product
Table 124. LEO Pharma Recent Developments/Updates
Table 125. Kyowa Kirin Company Information
Table 126. Kyowa Kirin Description and Business Overview
Table 127. Kyowa Kirin Biologic Medications for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Kyowa Kirin Biologic Medications for Psoriasis Product
Table 129. Kyowa Kirin Recent Developments/Updates
Table 130. Boehringer Ingelheim Pharmaceuticals Company Information
Table 131. Boehringer Ingelheim Pharmaceuticals Description and Business Overview
Table 132. Boehringer Ingelheim Pharmaceuticals Biologic Medications for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Boehringer Ingelheim Pharmaceuticals Biologic Medications for Psoriasis Product
Table 134. Boehringer Ingelheim Pharmaceuticals Recent Developments/Updates
Table 135. Pfizer Company Information
Table 136. Pfizer Description and Business Overview
Table 137. Pfizer Biologic Medications for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Pfizer Biologic Medications for Psoriasis Product
Table 139. Pfizer Recent Developments/Updates
Table 140. Samsung Bioepis Company Information
Table 141. Samsung Bioepis Description and Business Overview
Table 142. Samsung Bioepis Biologic Medications for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Samsung Bioepis Biologic Medications for Psoriasis Product
Table 144. Samsung Bioepis Recent Developments/Updates
Table 145. Qilu Pharmaceutical Company Information
Table 146. Qilu Pharmaceutical Description and Business Overview
Table 147. Qilu Pharmaceutical Biologic Medications for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Qilu Pharmaceutical Biologic Medications for Psoriasis Product
Table 149. Qilu Pharmaceutical Recent Developments/Updates
Table 150. Hanwha Chemical Company Information
Table 151. Hanwha Chemical Description and Business Overview
Table 152. Hanwha Chemical Biologic Medications for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Hanwha Chemical Biologic Medications for Psoriasis Product
Table 154. Hanwha Chemical Recent Developments/Updates
Table 155. China Medical System Company Information
Table 156. China Medical System Description and Business Overview
Table 157. China Medical System Biologic Medications for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 158. China Medical System Biologic Medications for Psoriasis Product
Table 159. China Medical System Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Biologic Medications for Psoriasis Distributors List
Table 163. Biologic Medications for Psoriasis Customers List
Table 164. Biologic Medications for Psoriasis Market Trends
Table 165. Biologic Medications for Psoriasis Market Drivers
Table 166. Biologic Medications for Psoriasis Market Challenges
Table 167. Biologic Medications for Psoriasis Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
Table 171. Authors List of This Report
List of Figures
Figure 1. Product Picture of Biologic Medications for Psoriasis
Figure 2. Global Biologic Medications for Psoriasis Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Biologic Medications for Psoriasis Market Share by Type: 2023 & 2030
Figure 4. TNF-α Inhibitors Product Picture
Figure 5. Interleukin Inhibitors Product Picture
Figure 6. Tyrosine Kinase Inhibitors Product Picture
Figure 7. Phosphodiesterase Inhibitors Product Picture
Figure 8. Other Product Picture
Figure 9. Global Biologic Medications for Psoriasis Market Value by Application (2024-2030) & (US$ Million)
Figure 10. Global Biologic Medications for Psoriasis Market Share by Application: 2023 & 2030
Figure 11. Hospital and Clinic
Figure 12. Retail Pharmacies
Figure 13. Other
Figure 14. Global Biologic Medications for Psoriasis Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Biologic Medications for Psoriasis Market Size (2019-2030) & (US$ Million)
Figure 16. Global Biologic Medications for Psoriasis Sales (2019-2030) & (K Units)
Figure 17. Global Biologic Medications for Psoriasis Average Price (US$/Unit) & (2019-2030)
Figure 18. Biologic Medications for Psoriasis Report Years Considered
Figure 19. Biologic Medications for Psoriasis Sales Share by Manufacturers in 2023
Figure 20. Global Biologic Medications for Psoriasis Revenue Share by Manufacturers in 2023
Figure 21. Global 5 and 10 Largest Biologic Medications for Psoriasis Players: Market Share by Revenue in Biologic Medications for Psoriasis in 2023
Figure 22. Biologic Medications for Psoriasis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 23. Global Biologic Medications for Psoriasis Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 24. North America Biologic Medications for Psoriasis Sales Market Share by Country (2019-2030)
Figure 25. North America Biologic Medications for Psoriasis Revenue Market Share by Country (2019-2030)
Figure 26. United States Biologic Medications for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Canada Biologic Medications for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Europe Biologic Medications for Psoriasis Sales Market Share by Country (2019-2030)
Figure 29. Europe Biologic Medications for Psoriasis Revenue Market Share by Country (2019-2030)
Figure 30. Germany Biologic Medications for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France Biologic Medications for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. Biologic Medications for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy Biologic Medications for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Russia Biologic Medications for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Biologic Medications for Psoriasis Sales Market Share by Region (2019-2030)
Figure 36. Asia Pacific Biologic Medications for Psoriasis Revenue Market Share by Region (2019-2030)
Figure 37. China Biologic Medications for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan Biologic Medications for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea Biologic Medications for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India Biologic Medications for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia Biologic Medications for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. China Taiwan Biologic Medications for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Southeast Asia Biologic Medications for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Biologic Medications for Psoriasis Sales Market Share by Country (2019-2030)
Figure 45. Mexico Biologic Medications for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Biologic Medications for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Biologic Medications for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Colombia Biologic Medications for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East and Africa Biologic Medications for Psoriasis Sales Market Share by Country (2019-2030)
Figure 50. Middle East and Africa Biologic Medications for Psoriasis Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Biologic Medications for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Biologic Medications for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Biologic Medications for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Biologic Medications for Psoriasis by Type (2019-2030)
Figure 55. Global Revenue Market Share of Biologic Medications for Psoriasis by Type (2019-2030)
Figure 56. Global Biologic Medications for Psoriasis Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Biologic Medications for Psoriasis by Application (2019-2030)
Figure 58. Global Revenue Market Share of Biologic Medications for Psoriasis by Application (2019-2030)
Figure 59. Global Biologic Medications for Psoriasis Price (US$/Unit) by Application (2019-2030)
Figure 60. Biologic Medications for Psoriasis Value Chain
Figure 61. Biologic Medications for Psoriasis Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
